PROGRESS‐AD: a phase 2 study to evaluate efficacy and safety of GSK4527226 (AL101), an anti‐sortilin monoclonal antibody, in patients with early Alzheimer’s disease

Sandra Machlitt‐Northen, Azza Abdelkarim, Christine Bailey, Balasubrahmanyam Budda, Stéphanie Bombois, Bruce Brew, Dimitra Brintziki, Brady Burgess, Sharon Cohen, Gopinath Ganji, Massimiliano Germani, Dave Inman, Tharaka Jayabalan, Catherine J Mummery, Lovingly Park, Christine Parker, Gary Romano, M · 2025

Read PROGRESS‐AD: a phase 2 study to evaluate efficacy and safety of GSK4527226 (AL101), an anti‐sortilin monoclonal antibody, in patients with early Alzheimer’s disease by Sandra Machlitt‐Northen, Azza Abdelkarim, Christine Bailey, Balasubrahmanyam Budda, Stéphanie Bombois, Bruce Brew, Dimitra Brintziki, Brady Burgess, Sharon Cohen, Gopinath Ganji, Massimiliano Germani, Dave Inman, Tharaka Jayabalan, Catherine J Mummery, Lovingly Park, Christine Parker, Gary Romano, M (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712613.txt.

Description

Sandra Machlitt-Northen and a large team of co-authors describe a phase 2 trial of an antibody drug for early Alzheimer's disease, in a 2025 paper. The drug aims to raise levels of progranulin, a protein that supports cell cleaning and calms inflammation.

Low progranulin is tied to higher disease risk. A receptor called sortilin drags progranulin down for disposal, and the antibody blocks that receptor. Early studies in healthy volunteers showed the drug was tolerated and raised progranulin in blood and spinal fluid. The new trial, named PROGRESS-AD, enrolls 282 patients with amyloid-confirmed early disease. It is randomized and double-blind, comparing the drug with a placebo on safety and effect.

Catalog record

CREATORSandra Machlitt‐Northen, Azza Abdelkarim, Christine Bailey, Balasubrahmanyam Budda, Stéphanie Bombois, Bruce Brew, Dimitra Brintziki, Brady Burgess, Sharon Cohen, Gopinath Ganji, Massimiliano Germani, Dave Inman, Tharaka Jayabalan, Catherine J Mummery, Lovingly Park, Christine Parker, Gary Romano, M
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712613

Browse the full library · About the Tower of Babel